Retatrutide: A game-changer for obesity) The FDA has been increasingly vocal about its concerns regarding these unapproved products. […]
Research & Clinical Trials
New dual-action drug produces 13% weight loss in people with type 2 diabetes
People with obesity or overweight and type 2 diabetes lost up to 13.1% of their body weight with […]
Research & Clinical Trials
For People With Diabetes, GLP-1 Drugs May Be Linked to Lower Odds of a Leading Cause of Blindness
As millions of Americans have started taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro to control their blood […]
Research & Clinical Trials
New Class Of Weight-Loss Drugs May Have Fewer Side Effects Than GLP-1s
Experimental Weight-Loss Drug Petrelintide Shows Promise With Fewer Stomach Side Effects A new type of obesity medication could […]